Interestingly, the expression levels of GAPDH were downregulated in the NDV-treated cells more than in the 2-DG-treated cells at some time points tested in both cancer cell lines, this result suggests that NDV may play an important role in inhibiting cancer cells glycolysis metabolism. The gene discussed is GAPDH; the disease is cancer.